Examining Ontario's universal influenza immunization program with a multi-strain dynamic model

被引:11
作者
Thommes, E. W. [1 ,2 ]
Chit, A. [3 ,4 ]
Meier, G. C. [5 ]
Bauch, C. T. [2 ,6 ]
机构
[1] GlaxoSmithKline Inc, Div Med, Mississauga, ON L5N 6L4, Canada
[2] Univ Guelph, Dept Math Stat, Guelph, ON N1G 2W1, Canada
[3] Sanofi Pasteur, Toronto, ON M2R 3T4, Canada
[4] Univ Toronto, Lesli Dan Fac Pharm, Toronto, ON M5S 3M2, Canada
[5] GlaxoSmithKline Inc, B-1300 Wavre, Belgium
[6] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada
关键词
Influenza; Dynamic transmission model; Universal vaccination; TIV; Ontario; Canada; SEASONAL INFLUENZA; VACCINE; IMPACT; TIME; TRANSMISSION; INFECTION; CHILDREN; EFFICACY; DISEASE; ENGLAND;
D O I
10.1016/j.vaccine.2014.06.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Seasonal influenza imposes a significant worldwide health burden each year. Mathematical models help us to understand how changes in vaccination affect this burden. Here, we develop a new dynamic transmission model which directly tracks the four dominant seasonal influenza strains/lineages, and use it to retrospectively examine the impact of the switch from a targeted to a universal influenza immunization program (UIIP) in the Canadian province of Ontario in 2000. According to our model results, averaged over the first four seasons post-UIIP, the rates of influenza-associated health outcomes in Ontario were reduced to about half of their pre-UIIP values. This is conservative compared to the results of a study estimating the UIIP impact from administrative data, though that study finds age-specific trends similar to those presented here. The strain interaction in our model, together with its flexible parameter calibration scheme, make it readily extensible to studying scenarios beyond the one explored here. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5098 / 5117
页数:20
相关论文
共 39 条
[1]   The rationale for quadrivalent influenza vaccines [J].
Ambrose, Christopher S. ;
Levin, Myron J. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (01) :81-88
[2]  
ANDERSON R M, 1991
[3]   Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Cho, I ;
Reisinger, K ;
Block, SL ;
Wittes, J ;
Iacuzio, D ;
Piedra, P ;
Treanor, J ;
King, J ;
Kotloff, K ;
Bernstein, DI ;
Hayden, FG ;
Zangwill, K ;
Yan, LH ;
Wolff, M .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175
[4]   The need for quadrivalent vaccine against seasonal influenza [J].
Belshe, Robert B. .
VACCINE, 2010, 28 :D45-D53
[5]   SENSITIVITY AND UNCERTAINTY ANALYSIS OF COMPLEX-MODELS OF DISEASE TRANSMISSION - AN HIV MODEL, AS AN EXAMPLE [J].
BLOWER, SM ;
DOWLATABADI, H .
INTERNATIONAL STATISTICAL REVIEW, 1994, 62 (02) :229-243
[6]   Low Rates of Influenza Immunization in Young Children Under Ontario's Universal Influenza Immunization Program [J].
Campitelli, Michael A. ;
Inoue, Miho ;
Calzavara, Andrew J. ;
Kwong, Jeffrey C. ;
Guttmann, Astrid .
PEDIATRICS, 2012, 129 (06) :E1421-E1430
[7]   Time lines of infection and disease in human influenza: A review of volunteer challenge studies [J].
Carrat, Fabrice ;
Vergu, Elisabeta ;
Ferguson, Neil M. ;
Lemaitre, Magali ;
Cauchemez, Simon ;
Leach, Steve ;
Valleron, Alain-Jacques .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (07) :775-785
[8]   EPIDEMIOLOGICAL MODELS WITH AGE STRUCTURE, PROPORTIONATE MIXING, AND CROSS-IMMUNITY [J].
CASTILLOCHAVEZ, C ;
HETHCOTE, HW ;
ANDREASEN, V ;
LEVIN, SA ;
LIU, WM .
JOURNAL OF MATHEMATICAL BIOLOGY, 1989, 27 (03) :233-258
[9]   Seasonal influenza in the United States, France, and Australia: transmission and prospects for control [J].
Chowell, G. ;
Miller, M. A. ;
Viboud, C. .
EPIDEMIOLOGY AND INFECTION, 2008, 136 (06) :852-864
[10]   The molecular epidemiology of influenza viruses [J].
Cox, NJ ;
Bender, CA .
SEMINARS IN VIROLOGY, 1995, 6 (06) :359-370